Veterinary Cancer Pioneers Podcast

ImpriMed
  • 4.9 (15)
  • MEDICINE
  • UPDATED MONTHLY

Welcome to the Veterinary Cancer Pioneers Podcast, hosted by Dr. Rachel Venable, a board-certified veterinary medical oncologist. We delve into the groundbreaking work of veterinary professionals who are dedicated to advancing the field of veterinary oncology.

  1. JAN 25

    Dr. Guannan Wang | Precision Oncology Through Genomics

    In this episode of the Veterinary Cancer Pioneers Podcast, host Dr. Rachel Venable welcomes Dr. Guannan Wang, founder of VetOmics, to discuss how comprehensive genomic profiling is advancing precision oncology for dogs. Dr. Wang shares her path from molecular biology research to veterinary cancer genomics, and explains why the field is shifting from "should we use genomics?" to "how do we do it well?" The conversation covers how genomic testing can guide therapy selection, support difficult diagnoses, and help identify true cancer drivers, while emphasizing the importance of real-world outcome follow-up and biomarker-guided combination strategies to improve patient care. 📝Transcripts are available at https://www.imprimedicine.com/podcast. To learn more about ImpriMed Personalized Prediction Profile, please visit https://www.imprimedicine.com/ppp Music Credit: Hazy by Beat Mekanik

    43 min

  2. 12/21/2025

    Dr. Doug Thamm | Comparative Oncology Frontiers

    In this episode of the Veterinary Cancer Pioneers Podcast, host Dr. Rachel Venable is joined by Dr. Doug Thamm, Stuart Presidential Chair in Oncology and Director of Clinical Research at the Colorado State University Flint Animal Cancer Center. Dr. Thamm discusses how naturally occurring cancers in dogs are advancing cancer drug development and informing treatment strategies in both veterinary and human medicine. He shares real-world examples of comparative oncology in action and the role clinical trials play in bringing new therapies to patients. The conversation also explores the challenges of oncology drug development, regulatory pathways, and emerging areas such as biologics, genomic sequencing, and AI-driven tools—offering a clear-eyed view of where veterinary oncology is headed. 📝Transcripts are available at https://www.imprimedicine.com/podcast. To learn more about ImpriMed Personalized Prediction Profile, please visit https://www.imprimedicine.com/ppp Music Credit: Hazy by Beat Mekanik

    51 min

  3. 11/02/2025

    Dr. Joseph Impellizeri | Targeted Electrochemotherapy in Practice

    In this episode of the Veterinary Cancer Pioneers Podcast, host Dr. Rachel Venable welcomes Dr. Joseph Impellizeri, a true trailblazer in targeted electrochemotherapy and gene electrotransfer immunotherapy. Dr. Impellizeri shares how electroporation-based treatments are transforming cancer care by allowing localized delivery of chemotherapy and immunotherapy with minimal side effects. He discusses how this technology has evolved from treating skin tumors to tackling complex cases like oral, nasal, and even bone cancers — and how it can complement traditional modalities such as surgery, chemotherapy, and radiation. The conversation also explores his groundbreaking work combining gene electrotransfer with PD-1 inhibitors, offering a glimpse into the future of veterinary oncology and more compassionate, targeted treatment options for patients. 📝Transcripts are available at https://www.imprimedicine.com/podcast. To learn more about ImpriMed Personalized Prediction Profile, please visit https://www.imprimedicine.com/ppp Music Credit: Hazy by Beat Mekanik

    47 min

  4. 10/06/2025

    Dr. Chad Johannes | Navigating Career Transitions in Oncology

    In this episode of the Veterinary Cancer Pioneers Podcast, host Dr. Rachel Venable welcomes Dr. Chad Johannes, Associate Professor and Executive Director of the Veterinary Teaching Hospital at Colorado State University and former medical director at Aratana Therapeutics, who also helped launch Palladia at Pfizer Animal Health (Now Zoetis). Dr. Johannes reflects on his path across private practice, industry, and academia — sharing practical lessons on burnout, career pivots, and the value of mentorship and flexibility in professional growth. The conversation explores how immunotherapy and AI are advancing precision oncology and how empowering general practitioners with options like CCNU, Laverdia, and Palladia can expand access to care. Tune in for a candid look at the economics and innovations shaping the next chapter of veterinary oncology. 📝Transcripts are available at https://www.imprimedicine.com/podcast. To learn more about ImpriMed Personalized Prediction Profile, please visit https://www.imprimedicine.com/ppp Music Credit: Hazy by Beat Mekanik

    46 min

  5. 09/07/2025

    Dr. Jeannette Kelly | Inside Solo Oncology Practice

    In this episode of the Veterinary Cancer Pioneers Podcast, host Dr. Rachel Venable welcomes Dr. Kelly to share insights from her career as a solo practitioner in veterinary oncology. Dr. Kelly reflects on the realities of running a private practice and the unique challenges and opportunities it presents. She highlights her open-minded approach to integrating a wide range of therapeutics and diagnostic tools, always with the goal of providing the best possible patient care. Throughout the conversation, Dr. Kelly also discusses how adaptability, clinical curiosity, and a patient-centered mindset have guided her work and shaped her contributions to the field. 📝Transcripts are available at https://www.imprimedicine.com/podcast. To learn more about ImpriMed Personalized Prediction Profile, please visit https://www.imprimedicine.com/ppp Music Credit: Hazy by Beat Mekanik

    45 min

  6. 08/02/2025

    Dr. David Vail | Bridging Human & Veterinary Cancer Care

    In this episode of the Veterinary Cancer Pioneers Podcast, host Dr. Rachel Venable welcomes Dr. David Vail, renowned veterinary oncologist, professor at the University of Wisconsin–Madison, and co-editor of the widely used Small Animal Clinical Oncology textbook. Dr. Vail reflects on the evolution of veterinary oncology over the past four decades, sharing pivotal developments such as the introduction of Tanovea and the wide-reaching impact of Cerenia. He explores the rise of comparative oncology and the increasingly bidirectional collaboration between veterinary and human medicine. The discussion highlights cutting-edge advances in immunotherapy and how combination therapies and naturally occurring canine cancer trials are shaping human clinical research. Tune in for a thoughtful look at the past, present, and future of oncology through the lens of a true pioneer. 📝Transcripts are available at https://www.imprimedicine.com/podcast. To learn more about ImpriMed Personalized Prediction Profile, please visit https://www.imprimedicine.com/ppp Music Credit: Hazy by Beat Mekanik

    46 min

  7. 05/25/2025

    Dr. Steven Dow | Using Repurposed Drugs Against Cancer

    In this episode of the Veterinary Cancer Pioneers Podcast, host Dr. Rachel Venable welcomes Dr. Steve Dow, professor of immunology at Colorado State University and Director of the Center for Immune and Regenerative Medicine. Dr. Dow shares insights from his groundbreaking work on myeloid-targeted immunotherapies and the innovative use of repurposed, FDA-approved drugs like losartan, palladia, and propranolol in treating canine cancers such as osteosarcoma and brain tumors. He also discusses the development of tumor vaccines, promising adjuvant trial results, and the critical role dogs play as translational models in advancing human cancer therapies. The episode highlights the future potential of bispecific antibodies and CAR-T cell therapies in both veterinary and human oncology. 📝Transcripts are available at https://www.imprimedicine.com/podcast. To learn more about ImpriMed Personalized Prediction Profile, please visit https://www.imprimedicine.com/ppp Music Credit: Hazy by Beat Mekanik

    34 min

  8. 05/04/2025

    Dr. Steven Suter | Pioneering Bone Marrow Transplants in Dogs

    In this episode of the Veterinary Cancer Pioneers Podcast, host Dr. Rachel Venable speaks with Dr. Steve Suter, a trailblazer in canine bone marrow transplantation, about his unexpected path into transplant research and the launch of the world's only academic bone marrow transplant program for dogs. Dr. Suter discusses the differences between autologous and allogeneic transplants, clinical protocols, and the emotional and logistical challenges behind this advanced treatment for canine lymphoma and leukemia. They delve into powerful case stories, donor matching hurdles, and the growing importance of early intervention and immunotherapy in veterinary oncology. Tune in to hear how Dr. Suter is reshaping cancer care for dogs—and why bone marrow transplants may offer new hope where traditional chemotherapy falls short. 📝Transcripts are available at https://www.imprimedicine.com/podcast. To learn more about ImpriMed Personalized Prediction Profile, please visit https://www.imprimedicine.com/personalized-prediction-profile Music Credit: Hazy by Beat Mekanik

    49 min
See All (32)

Ratings & Reviews

4.9
out of 5
15 Ratings

About

Welcome to the Veterinary Cancer Pioneers Podcast, hosted by Dr. Rachel Venable, a board-certified veterinary medical oncologist. We delve into the groundbreaking work of veterinary professionals who are dedicated to advancing the field of veterinary oncology.

Information